Cargando…

The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury

OBJECTIVES: To verify the protective effect of phosphocreatine on myocardium in an ischemic model and the possible mechanism of action. METHODS: The model of myocardial ischemia/reperfusion (I/R) was established by the ligation balloon method. 30 SD rats were randomly divided into three groups, n = ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen-xi, Guo, Jun-jun, Di, An-jie, Zhu, Yu, Han, Wei-min, Cheng, An-ran, Li, Cheng, Si, Rui-chan, Lan, Tian-shu, Zhang, Ran, Liu, Hong-li, Yan, Guo-liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847337/
https://www.ncbi.nlm.nih.gov/pubmed/33552599
http://dx.doi.org/10.1155/2021/8838151
_version_ 1783644911528050688
author Wang, Chen-xi
Guo, Jun-jun
Di, An-jie
Zhu, Yu
Han, Wei-min
Cheng, An-ran
Li, Cheng
Si, Rui-chan
Lan, Tian-shu
Zhang, Ran
Liu, Hong-li
Yan, Guo-liang
author_facet Wang, Chen-xi
Guo, Jun-jun
Di, An-jie
Zhu, Yu
Han, Wei-min
Cheng, An-ran
Li, Cheng
Si, Rui-chan
Lan, Tian-shu
Zhang, Ran
Liu, Hong-li
Yan, Guo-liang
author_sort Wang, Chen-xi
collection PubMed
description OBJECTIVES: To verify the protective effect of phosphocreatine on myocardium in an ischemic model and the possible mechanism of action. METHODS: The model of myocardial ischemia/reperfusion (I/R) was established by the ligation balloon method. 30 SD rats were randomly divided into three groups, n = 10 in each group. Sham operation group: the coronary artery was not blocked and observed for 120 minutes. The ischemia/reperfusion (I/R) group was given ischemia for 30 minutes and ischemia reperfusion for 90 minutes. Phosphocreatine (PCr) group: after 30 minutes of ischemia, the rats were intraperitoneally injected with PCr (200 mg/kg) for 90 minutes. The animal groups of myocardial ischemia/reperfusion model in vitro were the same as those in vivo. The heart was removed by thoracotomy and washed immediately in H-K buffer solution. Then, the heart was installed on the Langendorff instrument. The concentration of PCr perfusion fluid in the PCr group was 10 mmol/L. The changes in coronary blood flow in isolated myocardium were recorded. The heart rate and electrocardiogram were recorded by RM6240BT. At the end of the experiment, myocardial pathological sections and Cx43 immunofluorescence staining were made, and the contents of malondialdehyde (MDA) in myocardial tissue were detected. RESULTS: Phosphocreatinine treatment improved the myocardial ischemia model, performance in electrocardiogram (ECG) changes (ST segment apparent), and histological changes (decrease in necrotic myocardial cells, inflammatory cell infiltration, and a reduction in myocardial edema). At the same time, MDA decreased, while coronary blood flow and Cx43 expression significantly improved. CONCLUSIONS: Phosphocreatine can improve the electrocardiogram and restore histologic changes in ischemic myocardium and coronary blood flow. The postulated mechanism is by inhibiting the generation of free oxygen radicals and restoring the expression of Cx43 protein.
format Online
Article
Text
id pubmed-7847337
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-78473372021-02-04 The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury Wang, Chen-xi Guo, Jun-jun Di, An-jie Zhu, Yu Han, Wei-min Cheng, An-ran Li, Cheng Si, Rui-chan Lan, Tian-shu Zhang, Ran Liu, Hong-li Yan, Guo-liang Cardiol Res Pract Research Article OBJECTIVES: To verify the protective effect of phosphocreatine on myocardium in an ischemic model and the possible mechanism of action. METHODS: The model of myocardial ischemia/reperfusion (I/R) was established by the ligation balloon method. 30 SD rats were randomly divided into three groups, n = 10 in each group. Sham operation group: the coronary artery was not blocked and observed for 120 minutes. The ischemia/reperfusion (I/R) group was given ischemia for 30 minutes and ischemia reperfusion for 90 minutes. Phosphocreatine (PCr) group: after 30 minutes of ischemia, the rats were intraperitoneally injected with PCr (200 mg/kg) for 90 minutes. The animal groups of myocardial ischemia/reperfusion model in vitro were the same as those in vivo. The heart was removed by thoracotomy and washed immediately in H-K buffer solution. Then, the heart was installed on the Langendorff instrument. The concentration of PCr perfusion fluid in the PCr group was 10 mmol/L. The changes in coronary blood flow in isolated myocardium were recorded. The heart rate and electrocardiogram were recorded by RM6240BT. At the end of the experiment, myocardial pathological sections and Cx43 immunofluorescence staining were made, and the contents of malondialdehyde (MDA) in myocardial tissue were detected. RESULTS: Phosphocreatinine treatment improved the myocardial ischemia model, performance in electrocardiogram (ECG) changes (ST segment apparent), and histological changes (decrease in necrotic myocardial cells, inflammatory cell infiltration, and a reduction in myocardial edema). At the same time, MDA decreased, while coronary blood flow and Cx43 expression significantly improved. CONCLUSIONS: Phosphocreatine can improve the electrocardiogram and restore histologic changes in ischemic myocardium and coronary blood flow. The postulated mechanism is by inhibiting the generation of free oxygen radicals and restoring the expression of Cx43 protein. Hindawi 2021-01-22 /pmc/articles/PMC7847337/ /pubmed/33552599 http://dx.doi.org/10.1155/2021/8838151 Text en Copyright © 2021 Chen-xi Wang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Chen-xi
Guo, Jun-jun
Di, An-jie
Zhu, Yu
Han, Wei-min
Cheng, An-ran
Li, Cheng
Si, Rui-chan
Lan, Tian-shu
Zhang, Ran
Liu, Hong-li
Yan, Guo-liang
The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury
title The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury
title_full The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury
title_fullStr The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury
title_full_unstemmed The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury
title_short The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury
title_sort protective effect of cx43 protein-mediated phosphocreatine on myocardial ischemia/reperfusion injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847337/
https://www.ncbi.nlm.nih.gov/pubmed/33552599
http://dx.doi.org/10.1155/2021/8838151
work_keys_str_mv AT wangchenxi theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT guojunjun theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT dianjie theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT zhuyu theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT hanweimin theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT chenganran theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT licheng theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT siruichan theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT lantianshu theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT zhangran theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT liuhongli theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT yanguoliang theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT wangchenxi protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT guojunjun protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT dianjie protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT zhuyu protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT hanweimin protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT chenganran protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT licheng protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT siruichan protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT lantianshu protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT zhangran protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT liuhongli protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury
AT yanguoliang protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury